Day: September 14, 2020

SPARTA, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on developing its clinically-validated and patent-protected PLxGuard™ delivery system to provide more effective and safer products, VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”™), announced today that Natasha Giordano, President and Chief Executive Officer, and Rita O’Connor, Chief Financial Officer, will present virtually at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit as follows:The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.plxpharma.com, under the ‘Investors Relations’ Section.About VAZALOREVAZALORE 325 mg is an FDA-approved liquid-filled...

More than 450 of the planned ~500 patients enrolledInterim superiority analysis expected around year-end 2020Call with KOL Dr. Manuel Hidalgo on September 29, 2020 at 10:00 am ETLYON, France and CAMBRIDGE, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announces the hosting of a Key Opinion Leader (KOL) Event to discuss the medical need in pancreatic cancer and the potential role of eryaspase in this setting. TRYbeCA-1, the pivotal Phase 3 clinical trial evaluating ERYTECH’s lead product candidate, eryaspase, in second-line metastatic pancreatic cancer, has randomized more than 450 of the approximately 500 patients to be enrolled in the trial. The...

Plus de 450 des 500 patients prévus dans l’étude ont été recrutésUne analyse intermédiaire d’efficacité est attendue vers la fin de l’année 2020Conférence téléphonique avec un leader d’opinion, le Dr. Manuel Hidalgo, le mardi 29 septembre 2020 à 16h00 (heure de Paris)LYON, France, 14 sept. 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les globules rouges, annonce l’organisation d’un événement avec un leader d’opinion autour du besoin médical dans le cancer du pancréas et du rôle potentiel d’eryaspase dans cette indication.TRYbeCA-1, l’essai clinique pivot de phase 3 évaluant le produit candidat phare d’ERYTECH, eryaspase, dans le traitement de seconde...

NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) — Japan Smaller Capitalization Fund, Inc. (NYSE: JOF) (the “Fund”) announced that it will hold its 2020 Annual Meeting of Shareholders (the “Meeting”) on Tuesday, November 24, 2020, at 10:30 A.M. to consider the election of three Directors. The Fund’s Board of Directors previously approved the declassification of the Fund’s board pursuant to a process that is being implemented over a three-year period. As a result, the three Directors nominated for election will serve for a term expiring in 2021 and until their successors are elected and qualified. The record date for determining shareholders entitled to participate in the Meeting is September 21, 2020.The Fund invests primarily in the securities of smaller capitalization companies in Japan and is designed for investors seeking long-term...

LISLE, Ill., Sept. 14, 2020 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) will be presenting at the Sidoti Virtual Investor Conference on September 23, 2020 at 3:15 p.m. (EDT). You may access a live webcast of the virtual event using this link or from the Investors section of the CTS Corporation website at www.ctscorp.com. The webcast will also be available for replay on the CTS Corporation website for 30 days following the presentation.About CTSCTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, telecommunications/IT, and transportation markets.For more information, visit www.ctscorp.com.CTS...

CAMBRIDGE, Mass., Sept. 14, 2020 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today announced the appointment of Michelle Quinn Smith as Chief Human Resources Officer. Ms. Smith brings over 30 years of experience in human resources to Voyager, including leadership roles at Flagship Pioneering, Takeda Pharmaceuticals, Genzyme, and Sanofi.“We are excited to welcome Michelle to Voyager in this important role. She brings a strong track record of purpose-driven, inclusive leadership, and will be a great addition to our team,” said Andre Turenne, President and CEO of Voyager. “We believe Michelle’s experience in driving organizational strategy in R&D organizations and growth companies will be instrumental...

IRVING, Texas, Sept. 14, 2020 (GLOBE NEWSWIRE) — Forterra, Inc. (“Forterra” or “the Company”) (NASDAQ: FRTA), a leading manufacturer of water and drainage infrastructure pipe and products in the United States and Eastern Canada, today announced that on September 11, 2020, the Company delivered notice to the administrative agent for its senior term loan regarding the voluntary prepayment of an aggregate of $100 million outstanding under the senior term loan to be made on September 17, 2020. Following this prepayment and the settlement of another $16 million the Company has contracted to repurchase, the Company will have voluntarily prepaid approximately $139 million under the senior term loan in 2020, and the outstanding balance will be approximately $485 million.Forterra’s CEO Karl Watson, Jr. commented, “As we continue to execute...

IRVING, Texas, Sept. 14, 2020 (GLOBE NEWSWIRE) — Forterra, Inc. (the “Company” or “Forterra”) (NASDAQ: FRTA) announced today that the Company’s largest stockholder, an affiliate of Lone Star Funds (the “Selling Stockholder”), intends to offer for sale in an underwritten secondary offering 10,000,000 shares of common stock of the Company.  The Selling Stockholder will also grant the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock of the Company.  The Selling Stockholder will receive all of the proceeds from the sale of shares in this offering.  No shares are being sold by the Company. Credit Suisse, BofA Securities and Citigroup are acting as joint book-running managers and underwriters for the offering.The Company has filed a shelf registration statement (including a prospectus) on Form...

Barranquilla, Colombia, Sept. 14, 2020 (GLOBE NEWSWIRE) — Tecnoglass, Inc. (NASDAQ: TGLS) (“Tecnoglass” or the “Company”), a leading manufacturer of architectural glass, windows, and associated aluminum products for the global commercial and residential construction industries, today announced that its Board of Directors has declared a quarterly cash dividend of $0.0275 per share, or $0.11 per share on an annualized basis, for the third quarter of 2020. The dividend will be paid on October 30, 2020 to shareholders of record as of the close of business on September 30, 2020. About TecnoglassTecnoglass Inc. is a leading manufacturer of architectural glass, windows, and associated aluminum products for the global commercial and residential construction industries. Tecnoglass is the #1 architectural glass transformation...

AUSTIN, Texas, Sept. 14, 2020 (GLOBE NEWSWIRE) — Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading provider of professional testing, inspection, engineering, program management and consulting services, announced today that Joe Boyer, CEO, and David Quinn, CFO, will attend the Lake Street Capital Markets Best Ideas Growth (BIG4) Conference to be held virtually on Thursday, September 17, 2020.    About Atlas Technical ConsultantsHeadquartered in Austin, Texas, Atlas is a leading provider of professional testing, inspection engineering and consulting services under the name Atlas Technical Consultants, offering solutions to public and private sector clients in the transportation, commercial, water, government, education and industrial markets. With more than 100 offices in 40 states and 3,200+ employees,...